Ubiquitin-conjugating enzyme E2T (UBE2T), a key mediator of DNA damage repair and genomic stability [50], is overexpressed in CRC patients and promotes tumor progression through ubiquitin-mediated degradation of p53 [51]. This evidence concerns the gene TP53 and neoplasm.